ReviewBlood2016
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.
Jae H Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
241 papers cite itlatest 60 shown
this paperpooled ittrialcites it